Slingshot members are tracking this event:
Celgene Settles REVLIMID Patent Litigation with Natco Pharma Ltd. of India, Natco's U.S. partner, Arrow International Limited, and Arrow's parent company, Watson Laboratories, Inc. (a wholly-owned subsidiary of Allergan plc)
Do you think this event is important to the companies below? How will it affect their stock price?
|Impact on Stocks
Slingshot Insights Explained
Dec 22, 2015
Don’t see a project related to the catalyst you care about?
Related Keywords Revlimid, Patent, Litigation, Settlement, Lenalidomide